CNMD: Conmed Corp Financial Statements
Balance sheet, income statement, and cash flow statements for Conmed Corp (CNMD).
$2.11B Market Cap.
CNMD Market Cap. (MRY)
CNMD Shares Outstanding (MRY)
CNMD Assets (MRY)
Total Assets
$2.31B
Total Liabilities
$1.34B
Total Investments
$0
CNMD Income (MRY)
Revenue
$1.31B
Net Income
$132.42M
Operating Expense
$532.71M
CNMD Cash Flow (MRY)
CF Operations
$166.97M
CF Investing
-$13.08M
CF Financing
-$151.00M
CNMD Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total Assets | $2,306,247,000 (0.27%) | $2,300,021,000 (0.11%) | $2,297,592,000 (30.10%) | $1,766,017,000 (0.82%) |
Assets Current | $640,007,000 (3.96%) | $615,649,000 (5.92%) | $581,226,000 (26.32%) | $460,123,000 (10.43%) |
Assets Non-Current | $1,666,240,000 (-1.08%) | $1,684,372,000 (-1.86%) | $1,716,366,000 (31.43%) | $1,305,894,000 (-2.18%) |
Goodwill & Intangible Assets | $1,423,021,000 (-2.29%) | $1,456,328,000 (-2.73%) | $1,497,228,000 (37.54%) | $1,088,577,000 (-2.80%) |
Shareholders Equity | $962,681,000 (15.40%) | $834,222,000 (11.89%) | $745,545,000 (-5.08%) | $785,435,000 (10.77%) |
Property Plant & Equipment Net | $115,793,000 (-4.08%) | $120,722,000 (4.42%) | $115,611,000 (6.20%) | $108,863,000 (-2.28%) |
Cash & Equivalents | $24,459,000 (0.67%) | $24,296,000 (-16.05%) | $28,942,000 (38.83%) | $20,847,000 (-23.79%) |
Accumulated Other Comprehensive Income | -$58,857,000 (-17.32%) | -$50,170,000 (13.29%) | -$57,858,000 (-6.74%) | -$54,203,000 (14.88%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $346,719,000 (8.92%) | $318,324,000 (-4.21%) | $332,320,000 (43.46%) | $231,644,000 (18.87%) |
Trade & Non-Trade Receivables | $237,733,000 (-1.88%) | $242,279,000 (26.62%) | $191,345,000 (4.06%) | $183,882,000 (3.80%) |
Trade & Non-Trade Payables | $102,248,000 (15.90%) | $88,224,000 (20.21%) | $73,393,000 (26.11%) | $58,197,000 (9.17%) |
Accumulated Retained Earnings (Deficit) | $560,277,000 (23.81%) | $452,531,000 (9.67%) | $412,631,000 (-16.91%) | $496,605,000 (8.57%) |
Tax Assets | $0 (0%) | $11,211,000 (16.18%) | $9,650,000 (-0.07%) | $9,657,000 (41.14%) |
Tax Liabilities | $74,076,000 (21.63%) | $60,902,000 (-8.73%) | $66,725,000 (-2.64%) | $68,537,000 (18.42%) |
Total Debt | $905,781,000 (-6.99%) | $973,848,000 (-7.68%) | $1,054,822,000 (54.07%) | $684,656,000 (-9.15%) |
Debt Current | $715,000 (0.99%) | $708,000 (-98.98%) | $69,746,000 (469.40%) | $12,249,000 (-33.48%) |
Debt Non-Current | $905,066,000 (-7.00%) | $973,140,000 (-1.21%) | $985,076,000 (46.50%) | $672,407,000 (-8.54%) |
Total Liabilities | $1,343,566,000 (-8.34%) | $1,465,799,000 (-5.56%) | $1,552,047,000 (58.28%) | $980,582,000 (-5.95%) |
Liabilities Current | $278,130,000 (-10.49%) | $310,729,000 (4.78%) | $296,552,000 (50.80%) | $196,646,000 (3.39%) |
Liabilities Non-Current | $1,065,436,000 (-7.76%) | $1,155,070,000 (-8.00%) | $1,255,495,000 (60.15%) | $783,936,000 (-8.04%) |
CNMD Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Revenues | $1,307,015,000 (5.00%) | $1,244,744,000 (19.06%) | $1,045,472,000 (3.45%) | $1,010,635,000 (17.18%) |
Cost of Revenue | $573,983,000 (0.96%) | $568,499,000 (19.88%) | $474,227,000 (7.15%) | $442,599,000 (10.06%) |
Selling General & Administrative Expense | $478,280,000 (-4.92%) | $503,040,000 (10.79%) | $454,039,000 (9.47%) | $414,754,000 (10.95%) |
Research & Development Expense | $54,426,000 (3.47%) | $52,602,000 (11.56%) | $47,152,000 (8.23%) | $43,565,000 (7.64%) |
Operating Expenses | $532,706,000 (-4.13%) | $555,642,000 (-9.39%) | $613,202,000 (33.47%) | $459,446,000 (10.80%) |
Interest Expense | $37,297,000 (-6.23%) | $39,775,000 (37.61%) | $28,905,000 (-18.54%) | $35,485,000 (-19.45%) |
Income Tax Expense | $30,606,000 (86.98%) | $16,369,000 (68.41%) | $9,720,000 (-7.98%) | $10,563,000 (233.47%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | $132,423,000 (105.44%) | $64,459,000 (179.99%) | -$80,582,000 (-228.84%) | $62,542,000 (557.16%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | $132,423,000 (105.44%) | $64,459,000 (179.99%) | -$80,582,000 (-228.84%) | $62,542,000 (557.16%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | $132,423,000 (105.44%) | $64,459,000 (179.99%) | -$80,582,000 (-228.84%) | $62,542,000 (557.16%) |
Weighted Average Shares | $30,890,853 (0.45%) | $30,752,199 (0.89%) | $30,482,412 (4.22%) | $29,247,120 (2.26%) |
Weighted Average Shares Diluted | - | - | - | - |
Earning Before Interest & Taxes (EBIT) | $200,326,000 (66.10%) | $120,603,000 (387.44%) | -$41,957,000 (-138.64%) | $108,590,000 (137.85%) |
Gross Profit | $733,032,000 (8.40%) | $676,245,000 (18.38%) | $571,245,000 (0.56%) | $568,036,000 (23.41%) |
Operating Income | $200,326,000 (66.10%) | $120,603,000 (387.44%) | -$41,957,000 (-138.64%) | $108,590,000 (137.85%) |
CNMD Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Net Cash Flow from Investing | -$13,084,000 (34.68%) | -$20,032,000 (91.97%) | -$249,529,000 (-1578.52%) | -$14,866,000 (-9.00%) |
Net Cash Flow from Financing | -$151,000,000 (-36.74%) | -$110,432,000 (-149.08%) | $225,000,000 (321.57%) | -$101,548,000 (-95.06%) |
Net Cash Flow from Operations | $166,968,000 (33.20%) | $125,348,000 (275.69%) | $33,365,000 (-70.15%) | $111,770,000 (73.20%) |
Net Cash Flow / Change in Cash & Cash Equivalents | $163,000 (103.51%) | -$4,646,000 (-157.39%) | $8,095,000 (224.37%) | -$6,509,000 (-533.93%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | -$227,744,000 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Capital Expenditure | -$13,084,000 (31.25%) | -$19,032,000 (12.64%) | -$21,785,000 (-46.54%) | -$14,866,000 (-51.91%) |
Issuance (Repayment) of Debt Securities | -$72,000,000 (18.18%) | -$88,000,000 (-133.76%) | $260,647,000 (420.82%) | -$81,243,000 (-209.50%) |
Issuance (Purchase) of Equity Shares | $0 (0%) | $0 (0%) | $72,000,000 (0%) | $0 (0%) |
Payment of Dividends & Other Cash Distributions | -$24,651,000 (-0.61%) | -$24,502,000 (-2.26%) | -$23,960,000 (-3.03%) | -$23,256,000 (-1.92%) |
Effect of Exchange Rate Changes on Cash | -$2,721,000 (-678.94%) | $470,000 (163.43%) | -$741,000 (60.27%) | -$1,865,000 (-169.95%) |
Share Based Compensation | $25,558,000 (5.36%) | $24,257,000 (11.63%) | $21,729,000 (33.02%) | $16,335,000 (24.59%) |
Depreciation Amortization & Accretion | $16,605,000 (2.50%) | $16,200,000 (0.90%) | $16,055,000 (-2.66%) | $16,494,000 (-8.59%) |
CNMD Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Gross Margin | 56.10% (3.31%) | 54.30% (-0.55%) | 54.60% (-2.85%) | 56.20% (5.24%) |
Profit Margin | 10.10% (94.23%) | 5.20% (167.53%) | -7.70% (-224.19%) | 6.20% (463.64%) |
EBITDA Margin | 16.60% (50.91%) | 11.00% (540.00%) | -2.50% (-120.16%) | 12.40% (67.57%) |
Return on Average Equity (ROAE) | 14.60% (78.05%) | 8.20% (174.55%) | -11.00% (-232.53%) | 8.30% (492.86%) |
Return on Average Assets (ROAA) | 5.70% (103.57%) | 2.80% (173.68%) | -3.80% (-205.56%) | 3.60% (620.00%) |
Return on Sales (ROS) | 15.30% (57.73%) | 9.70% (342.50%) | -4.00% (-137.38%) | 10.70% (101.89%) |
Return on Invested Capital (ROIC) | 13.30% (64.20%) | 8.10% (379.31%) | -2.90% (-130.85%) | 9.40% (147.37%) |
Dividend Yield | 1.20% (71.43%) | 0.70% (-22.22%) | 0.90% (50.00%) | 0.60% (-14.29%) |
Price to Earnings Ratio (P/E) | 15.95 (-69.41%) | 52.15 (257.67%) | -33.08 (-149.93%) | 66.24 (-80.48%) |
Price to Sales Ratio (P/S) | 1.62 (-40.21%) | 2.71 (4.72%) | 2.58 (-37.01%) | 4.1 (10.45%) |
Price to Book Ratio (P/B) | 2.2 (-45.60%) | 4.04 (11.40%) | 3.62 (-31.35%) | 5.28 (16.84%) |
Debt to Equity Ratio (D/E) | 1.4 (-20.55%) | 1.76 (-15.61%) | 2.08 (66.83%) | 1.25 (-15.10%) |
Earnings Per Share (EPS) | 4.29 (104.29%) | 2.1 (178.36%) | -2.68 (-225.23%) | 2.14 (548.48%) |
Sales Per Share (SPS) | 42.31 (4.53%) | 40.48 (18.02%) | 34.3 (-0.74%) | 34.55 (14.60%) |
Free Cash Flow Per Share (FCFPS) | 4.98 (44.11%) | 3.46 (809.74%) | 0.38 (-88.53%) | 3.31 (73.09%) |
Book Value Per Share (BVPS) | 31.16 (14.88%) | 27.13 (10.91%) | 24.46 (-8.93%) | 26.86 (8.33%) |
Tangible Assets Book Value Per Share (TABVPS) | 28.59 (4.22%) | 27.43 (4.49%) | 26.26 (13.36%) | 23.16 (4.88%) |
Enterprise Value Over EBIT (EV/EBIT) | 15 (-58.33%) | 36 (140.91%) | -88 (-300.00%) | 44 (-48.84%) |
Enterprise Value Over EBITDA (EV/EBITDA) | 13.9 (-56.27%) | 31.8 (122.23%) | -143.05 (-470.45%) | 38.62 (-37.65%) |
Asset Turnover | 0.57 (5.59%) | 0.54 (8.48%) | 0.49 (-13.91%) | 0.57 (16.16%) |
Current Ratio | 2.3 (16.15%) | 1.98 (1.07%) | 1.96 (-16.24%) | 2.34 (6.80%) |
Dividends | $0.8 (0.00%) | $0.8 (0.00%) | $0.8 (0.00%) | $0.8 (0.00%) |
Free Cash Flow (FCF) | $153,884,000 (44.74%) | $106,316,000 (818.10%) | $11,580,000 (-88.05%) | $96,904,000 (77.01%) |
Enterprise Value (EV) | $3,016,513,979 (-30.65%) | $4,349,962,312 (17.40%) | $3,705,282,000 (-23.29%) | $4,830,146,731 (22.44%) |
Earnings Before Tax (EBT) | $163,029,000 (101.70%) | $80,828,000 (214.06%) | -$70,862,000 (-196.93%) | $73,105,000 (4460.51%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | $216,931,000 (58.57%) | $136,803,000 (628.16%) | -$25,902,000 (-120.71%) | $125,084,000 (96.37%) |
Invested Capital | $1,486,418,000 (0.26%) | $1,482,516,000 (-3.08%) | $1,529,692,000 (33.64%) | $1,144,603,000 (-1.98%) |
Working Capital | $361,877,000 (18.68%) | $304,920,000 (7.11%) | $284,674,000 (8.05%) | $263,477,000 (16.35%) |
Tangible Asset Value | $883,226,000 (4.69%) | $843,693,000 (5.41%) | $800,364,000 (18.15%) | $677,440,000 (7.24%) |
Market Capitalization | $2,114,169,979 (-37.22%) | $3,367,673,312 (24.64%) | $2,701,961,000 (-34.83%) | $4,146,071,731 (29.43%) |
Average Equity | $908,018,250 (14.83%) | $790,768,500 (8.16%) | $731,099,000 (-2.88%) | $752,796,750 (8.76%) |
Average Assets | $2,304,215,500 (-0.56%) | $2,317,134,500 (9.72%) | $2,111,905,250 (20.19%) | $1,757,173,750 (0.85%) |
Invested Capital Average | $1,508,436,750 (0.69%) | $1,498,032,750 (2.51%) | $1,461,372,000 (26.91%) | $1,151,510,500 (-3.41%) |
Shares | 30,890,853 (0.45%) | 30,752,199 (0.89%) | 30,482,412 (4.22%) | 29,247,120 (2.26%) |